PMID- 25630263 OWN - NLM STAT- MEDLINE DCOM- 20151014 LR - 20181113 IS - 1469-7793 (Electronic) IS - 0022-3751 (Print) IS - 0022-3751 (Linking) VI - 593 IP - 2 DP - 2015 Jan 15 TI - Ageing and neurotrophic signalling effects on diaphragm neuromuscular function. PG - 431-40 LID - 10.1113/jphysiol.2014.282244 [doi] AB - The age-related mechanisms underlying sarcopenia are largely unknown. We hypothesize that age-related neuromuscular changes depend on brain-derived neurotrophic factor (BDNF) acting through the tropomyosin-related kinase receptor B (TrkB). Maximal specific force and neuromuscular transmission failure were assessed at 6, 18 and 24 months following control, BDNF or phosphoprotein phosphatase 1 derivative (1NMPP1) treatment in male TrkB(F616A) mice. Phosphoprotein phosphatase-1 derivatives such as 1NMPP1 inhibit TrkB kinase activity as a result of this single amino acid mutation in the ATP binding domain. Maximal twitch and isometric tetanic force were reduced at 24 months compared to 6 and 18 months (P < 0.001). Neuromuscular transmission failure significantly increased at 18 and 24 months compared to 6 months (age x treatment interaction: P < 0.001). Neuromuscular transmission was improved following BDNF at 6 and 18 months and was impaired only at 6 months following 1NMPP1 treatment. Age and inhibition of TrkB kinase activity had similar effects on neuromuscular transmission failure, supporting a critical role for BDNF/TrkB signalling on neuromuscular changes in ageing. These results suggest that an age-related loss of endogenous BDNF precedes reductions in TrkB kinase activity in the diaphragm muscle. CI - (c) 2014 The Authors. The Journal of Physiology (c) 2014 The Physiological Society. FAU - Greising, Sarah M AU - Greising SM AD - Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Rochester, MN 55905, USA. FAU - Ermilov, Leonid G AU - Ermilov LG FAU - Sieck, Gary C AU - Sieck GC FAU - Mantilla, Carlos B AU - Mantilla CB LA - eng GR - R01 AG044615/AG/NIA NIH HHS/United States GR - T32 HL105355/HL/NHLBI NIH HHS/United States GR - R01-AG044615/AG/NIA NIH HHS/United States GR - T32-HL105355/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20141201 PL - England TA - J Physiol JT - The Journal of physiology JID - 0266262 RN - 0 (1NMPP1 compound) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Pyrazoles) RN - 0 (Pyrimidines) RN - EC 2.7.10.1 (Receptor, trkB) SB - IM MH - Aging/*metabolism/physiology MH - Animals MH - Brain-Derived Neurotrophic Factor/metabolism/*pharmacology MH - Diaphragm/drug effects/growth & development/*metabolism/physiology MH - Male MH - Mice MH - *Muscle Contraction MH - Mutation MH - Pyrazoles/pharmacology MH - Pyrimidines/pharmacology MH - Receptor, trkB/genetics/metabolism MH - *Signal Transduction PMC - PMC4303387 EDAT- 2015/01/30 06:00 MHDA- 2015/10/16 06:00 PMCR- 2016/01/15 CRDT- 2015/01/30 06:00 PHST- 2014/08/08 00:00 [received] PHST- 2014/10/23 00:00 [accepted] PHST- 2015/01/30 06:00 [entrez] PHST- 2015/01/30 06:00 [pubmed] PHST- 2015/10/16 06:00 [medline] PHST- 2016/01/15 00:00 [pmc-release] AID - 10.1113/jphysiol.2014.282244 [doi] PST - ppublish SO - J Physiol. 2015 Jan 15;593(2):431-40. doi: 10.1113/jphysiol.2014.282244. Epub 2014 Dec 1.